MitoTEMPO hydrate

167 Cited Publications
Kundenbewertung

Based on 167 publication(s) in Google Scholar

MitoTEMPO hydrate is a mitochondria-targeted antioxidant. MitoTEMPO hydrate induces mitophagy by activating the PINK1/Parkin pathway, inhibits NLRP3 inflammasome activation, restores mitochondrial membrane potential, and improves renal function and podocyte injury. MitoTEMPO hydrate regulates Ca2+ homeostasis, inhibits Bnip3 overexpression, shortens action potential duration, and exerts antiarrhythmic effects. MitoTEMPO hydrate reverses premature senescence, reduces trabecular bone loss, and decreases cell apoptosis. MitoTEMPO hydrate can be used in studies of chronic kidney disease, age-related cardiac dysfunction, postmenopausal osteoporosis, and ischemic stroke.

Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.

  • Reinheit: 98.03%
  • CAS. Nr.: 1569257-94-8
  • Formel: C29H37ClN2O3P
  • Molecular Weight:528.04
  • Speicherung:

    -20°C, sealed storage, away from moisture

    * In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)

  • Biologische Aktivität
  • Chemical Information
  • Reinheit & Dokumentation
  • Verweise
  • Help & FAQs
You May Still Need

Publications Citing Use of MedChemExpress (MCE) MitoTEMPO hydrate

More
Customer Validation & Images
WBIF
  • IF
  • WB
  • WB

Alle NOD-like Receptor (NLR) Isoform-spezifische Produkte anzeigen

More
100 mg

Angebot einholen Auf Lager

Please select quantity
Amount: USD 0.00